Agarikonthe reference layer for psychedelic medicine
Blog Methodology Open the index
Find treatment · built Nov 18, 2026

Psychedelic therapy near you: what you can actually book in 2026

What you can book depends on the medicine and your state. Ketamine and esketamine are prescription medicines today. Psilocybin has licensed programs in Oregon and Colorado. MDMA and LSD are Schedule I under federal law, and 47 US trial sites are recruiting for studies of them. Here's the availability map, drawn from 2,024 US clinics and 322 recruiting trial sites in the index.

1,943US ketamine and esketamine clinics
67state-licensed psilocybin centers
322US trial sites recruiting
2,248clinics in the index worldwide

What's available where you live

By prescription

Ketamine & esketamine

We track 1,943 US clinics that give one or both; check any record to see exactly what it gives.

Ketamine is Schedule III (21 CFR 1308.13(c)) and FDA-labeled for anesthesia; psychiatric use is off-label, which FDA says prescribers generally may do when medically appropriate. (source, as of Oct 4, 2026)

Spravato (esketamine) is FDA-approved for adults with treatment-resistant depression; its REMS limits use to certified healthcare settings with at least 2 hours of monitoring. (source, as of Oct 4, 2026)

by prescription
Oregon & Colorado only

Psilocybin, licensed

21 Oregon service centers hold an active OHA license and 46 Colorado healing centers are approved on the state register. What each state's law allows, quoted with its source, is on the legal map. Expect a screening call before any session: a history of psychosis and lithium use are among the usual reasons for a no. We don't hold prices, so ask for the full cost of preparation, the session and integration before you book.

licensed program
41 states, by enrollment

Clinical trials

Where psilocybin, MDMA and LSD are being tested in the US. Medical teams run them, and most active studies target depression, PTSD, addiction and end-of-life distress.

322 US trial sites recruiting
Not near you (yet)

MDMA-assisted therapy

MDMA is a Schedule I controlled substance under federal law (21 CFR 1308.11(d)). (source, as of Oct 4, 2026) In August 2024 the FDA answered Lykos Therapeutics' application for MDMA-assisted therapy with a complete response letter, asking for another phase 3 trial. 18 US trial sites are recruiting for MDMA studies now.

Schedule I
72countries
7.1kmapped
Nov 18build
The live index
Find what's near you on the live map Open the index, pick a category, zoom to your state. 2,248 clinics and 581 recruiting trial sites, every one linked to its source. Explore the map →

The fastest honest paths, by goal

Depression, today: ketamine or esketamine at a clinic; ask specifically which of the two they give and what a full course costs. Psilocybin specifically: book Oregon or Colorado, or enroll in a trial anywhere else. PTSD: look at the MDMA trials; 18 US sites are recruiting now. Not sure: start from the legal map and work backward from what's lawful where you are.